PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, ...

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...

BBMP and the state health department will kick off a 100-day campaign to raise awareness and treat Tuberculosis in Bengaluru, ...

A new review was published in Oncotarget's Volume 15 on November 22, 2024, entitled "Mesenchymal stem cells – the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists." ...

In adults with chronic hepatitis B infection receiving viral suppression therapy, coupling an investigational small ...

Prostate cancer and other cancers characterized by “cold” tumors could become more responsive to checkpoint blockade if UBA1 is inhibited.

Innate immunity is an immunological subsystem that comprises the cells and mechanisms that provide the first line of defence from infection in a non-specific manner. Innate immune responses are ...

A study from the University of Michigan Health Rogel Cancer Center may have—at last—cracked the cold case of immunotherapy ...

A study from the University of Michigan Health Rogel Cancer Center may have, at last, cracked the cold case of immunotherapy resistance.The research ...

About 33% of ocular tuberculosis patients may relapse within 2 years of achieving clinical inactivity, with a poor initial ...

In recent decades, immunotherapy has transformed cancer treatment, offering effective options for diseases once considered ...

treatment-experienced (17) Arm 1: ABT-450/r (250/100 mg) + ABT-333 + RBV × 12 weeks Arm 2: ABT-450/r(150/100 mg) + ABT-333 + RBV × 12 weeks Arm 3: ABT-450/r(150/100 mg) + ABT-333 + RBV × 12 ...